Impact of corticosteroids on nivolumab activity in metastatic clear cell renal cell carcinoma

被引：0
|
作者：
Lefort, F. [1 ]
Dalban, C. [2 ]
Gross-Goupil, M. [1 ]
Laguerre, B. [3 ]
Barthelemy, P. [4 ]
Sarradin, V. [5 ]
Chanez, B. [6 ]
Negrier, S. [7 ]
Geoffrois, L. [8 ]
Gillon, P. [9 ]
De Vries, M. [10 ]
Ladoire, S. [11 ]
Bolognini, C. [12 ]
Laramas, M. [13 ]
Priou, F. [14 ]
Oudard, S. [15 ]
Chabot, S. [2 ]
Tantot, F. [16 ]
Escudier, B. [17 ]
Albiges, L. [17 ]
机构：
[1] Hop St Andre, CHU Bordeaux, Med Oncol, Bordeaux, France
[2] Ctr Leon Berard, Clin Res, Lyon, France
[3] Ctr Eugene Marquis, Med Oncol, Rennes, France
[4] Nouvel Hop Civil, CHU Strasbourg, Med Oncol, Strasbourg, France
[5] Inst Univ Canc Toulouse Oncopole, Med Oncol, Toulouse, France
[6] Inst Paoli Calmettes, Med Oncol, Marseille, France
[7] Ctr Leon Berard, Med Oncol, Lyon, France
[8] Inst Cancerol Lorraine Alexis Vautrin, Med Oncol, Vandoeuvre Les Nancy, France
[9] Ctr Antoine Lacassagne, Radiotherapy, Nice, France
[10] Inst Cancerol Ouest Paul Papin, Med Oncol, Angers, France
[11] Ctr Georges Francois Leclerc Dijon, Med Oncol, Dijon, France
[12] Hop Jean Minjoz, CHRU Besancon, Med Oncol, Besancon, France
[13] Grenoble Alpes Univ Hosp, Med Oncol, La Tronche, France
[14] Hop Oudairies, CHD Vendee, Med Oncol, La Roche Sur Yon, France
[15] Hop European George Pompidou, Med Oncol, Paris, France
[16] UNICANCER, Res & Dev, Paris, France
[17] Gustave Roussy, Med Oncol, Canc Campus, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
966P
引用
收藏
页码：391 / 391
页数：1
相关论文
共 50 条
  • [1] Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma
    Choueiri, Toni K.
    Fishman, Mayer N.
    Escudier, Bernard
    McDermott, David F.
    Drake, Charles G.
    Kluger, Harriet
    Stadler, Walter M.
    Perez-Gracia, Jose Luis
    McNeel, Douglas G.
    Curti, Brendan
    Harrison, Michael R.
    Plimack, Elizabeth R.
    Appleman, Leonard
    Fong, Lawrence
    Albiges, Laurence
    Cohen, Lewis
    Young, Tina C.
    Chasalow, Scott D.
    Ross-Macdonald, Petra
    Srivastava, Shivani
    Jure-Kunkel, Maria
    Kurland, John F.
    Simon, Jason S.
    Sznol, Mario
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (22) : 5461 - 5471
  • [2] Pseudoprogression: A case of metastatic renal clear cell carcinoma treated with nivolumab
    Tabei, Tadashi
    Tsuura, Yukio
    Kobayashi, Kazuki
    [J]. PATHOLOGY INTERNATIONAL, 2018, 68 (11) : 627 - 629
  • [3] Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma
    Fujiwara, Motohiro
    Shimada, Wataru
    Yokoyama, Minato
    Koyanagi, Anri
    Shintaku, Hiroshi
    Fukuda, Shohei
    Waseda, Yuma
    Tanaka, Hajime
    Yoshida, Soichiro
    Fujii, Yasuhisa
    [J]. IJU CASE REPORTS, 2024, 7 (04) : 293 - 296
  • [4] Lymphocytic myocarditis in a patient with metastatic clear cell renal cell carcinoma treated with Nivolumab
    Sauer, R.
    Kiewe, P.
    Desole, M.
    Schuler, M.
    Theissig, F.
    Roth, A.
    Mairinger, T.
    [J]. PATHOLOGE, 2017, 38 (06): : 535 - 539
  • [5] Clinical Activity of Ipilimumab Plus Nivolumab in Patients With Metastatic Non- Clear Cell Renal Cell Carcinoma
    Gupta, Ruby
    Ornstein, Moshe Chaim
    Li, Hong
    Allman, Kimberly D.
    Wood, Laura S.
    Gilligan, Timothy
    Garcia, Jorge A.
    Von Merveldt, Dendra
    Hammers, Hans J.
    Rini, Brian I.
    [J]. CLINICAL GENITOURINARY CANCER, 2020, 18 (06) : 429 - 435
  • [6] Nivolumab in metastatic renal cell carcinoma
    [J]. Nature Reviews Urology, 2015, 12 (2) : 63 - 63
  • [7] Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
    Singla, Nirmish
    Nirschl, Thomas R.
    Obradovic, Aleksandar Z.
    Shenderov, Eugene
    Lombardo, Kara
    Liu, Xiaopu
    Pons, Alice
    Zarif, Jelani C.
    Rowe, Steven P.
    Trock, Bruce J.
    Hammers, Hans J.
    Bivalacqua, Trinity J.
    Pierorazio, Phillip M.
    Deutsch, Julie S.
    Lotan, Tamara L.
    Taube, Janis M.
    Ged, Yasser M. A.
    Gorin, Michael A.
    Allaf, Mohamad E.
    Drake, Charles G.
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01)
  • [8] Immunomodulatory response to neoadjuvant nivolumab in non-metastatic clear cell renal cell carcinoma
    Nirmish Singla
    Thomas R. Nirschl
    Aleksandar Z. Obradovic
    Eugene Shenderov
    Kara Lombardo
    Xiaopu Liu
    Alice Pons
    Jelani C. Zarif
    Steven P. Rowe
    Bruce J. Trock
    Hans J. Hammers
    Trinity J. Bivalacqua
    Phillip M. Pierorazio
    Julie S. Deutsch
    Tamara L. Lotan
    Janis M. Taube
    Yasser M. A. Ged
    Michael A. Gorin
    Mohamad E. Allaf
    Charles G. Drake
    [J]. Scientific Reports, 14
  • [9] Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma
    Koshkin, Vadim S.
    Barata, Pedro C.
    Zhang, Tian
    George, Daniel J.
    Atkins, Michael B.
    Kelly, William J.
    Vogelzang, Nicholas J.
    Pal, Sumanta K.
    Hsu, JoAnn
    Appleman, Leonard J.
    Ornstein, Moshe C.
    Gilligan, Timothy
    Grivas, Petros
    Garcia, Jorge A.
    Rini, Brian I.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [10] Subcutaneous nivolumab versus intravenous nivolumab in patients with previously treated, advanced, or metastatic clear cell renal cell carcinoma
    Chacon, Matias Rodrigo
    Cutuli, Hernan J.
    Bracarda, Sergio
    Maruzzo, Marco
    Bourlon, Maria Teresa
    Jacobs, Carmel
    Perez-Valderrama, Begona
    Magri, Ignacio
    Richardet, Martin
    Centkowski, Piotr
    Fu, Simon Yuen Fai
    Gurman, Pablo
    Konduri, Srivani
    Yu, Zhuoxin
    Vezina, Heather
    George, Saby
    Albiges, Laurence
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345